Spots Global Cancer Trial Database for hematological neoplasms
Every month we try and update this database with for hematological neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease | NCT03844360 | Hematological N... | Bortezomib Eltrombopag Imatinib dasatinib Pegaspargase Anti-Infective ... PEGylated Recom... | 1 Day - 18 Years | Shandong University | |
| Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia | NCT02544230 | Neutropenia Fever Bacterial Infec... Fungal Infectio... Fever of Unknow... Hematological N... Sepsis | 18 Years - | Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne | ||
| Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT | NCT02634294 | Hematological N... Recurrence | Peg interferon ... | 14 Years - 60 Years | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | |
| Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia | NCT02544230 | Neutropenia Fever Bacterial Infec... Fungal Infectio... Fever of Unknow... Hematological N... Sepsis | 18 Years - | Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne | ||
| ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies. | NCT00440479 | Multiple Myelom... Hematological N... | Bortezomib | 18 Years - | Janssen-Cilag B.V. | |
| Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia | NCT02544230 | Neutropenia Fever Bacterial Infec... Fungal Infectio... Fever of Unknow... Hematological N... Sepsis | 18 Years - | Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne | ||
| The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants | NCT01021683 | Hematologic Neo... Neutropenia Fever | Itraconazole | 20 Years - | Janssen Korea, Ltd., Korea | |
| The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants | NCT01021683 | Hematologic Neo... Neutropenia Fever | Itraconazole | 20 Years - | Janssen Korea, Ltd., Korea | |
| Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies | NCT02223052 | Hematological N... Non-Hodgkin's L... Hodgkin's Lymph... Lymphoma Multiple Myelom... Acute Myeloid L... Leukemia Myelodysplastic... Neoplasms Melanoma Breast Cancer Metastatic Brea... Non-Small Cell ... Small Cell Lung... Renal Cell Carc... Glioblastoma Mu... Osteosarcoma Sarcoma Thyroid Cancer Genitourinary | CC-486 Vidaza | 18 Years - | Celgene | |
| ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies. | NCT00440479 | Multiple Myelom... Hematological N... | Bortezomib | 18 Years - | Janssen-Cilag B.V. | |
| Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases | NCT00582894 | Hematological N... Hematopoietic S... | Busulfex, Fluda... | 18 Years - 75 Years | University of Oklahoma | |
| VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands | NCT00440765 | Multiple Myelom... Hematological N... | bortezomib | 18 Years - | Janssen-Cilag B.V. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
